leisure time -WSS

leisure time

author：entertainment 2025-09-29 07:50:00 - browse：565

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Statins may not be needed by millions of people, study suggests

WSS

STAT Virtual Event: ASCO Recap, Live!

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Investment in vaccine development is lagging, report finds

STAT Virtual Event: ASCO Recap, Live!

Pharma companies must ensure equitable access to obesity drugs

Health Care Service Corp to buy Cigna Medicare Advantage plans

hotspot

leisure time

knowledge

Activists slam private health insurers over coverage restrictions

White House pharmacy plagued with problems, investigation finds

Bright Health sells Medicare Advantage business to Molina

Teladoc has a new CEO, but challenges remain the same

Continuity nursing helped my family in our darkest PICU moments

Venture capital firm's plans to take over Akron hospital face hurdles

Medical records are filled with copy

Philips to halt sales of sleep apnea machines in U.S.

Hepatitis C has a cure — but many Americans still lack access to it

Report captures long Covid’s disabling effects and policy challenges

knowledge

How generative AI ratchets up security threats for health systems

Medicare Advantage insurers face 0.2% cut to 2025 payments

FTC sues over Novant Health acquisition of two N.C. hospitals

The Affordable Care Act has saved billions in health care costs

The system is set up to fail children with medical complexity

5 takeaways from STAT's examination of Zynex Medical

hotspot

hotspot

knowledge

hotspot